Name: UMIN ID:
Unique ID issued by UMIN | UMIN000032585 |
---|---|
Receipt number | R000037039 |
Scientific Title | Phase II study of atezolizumab for advanced non-small-cell lung cancer patients not indicative of cytotoxic chemotherapy |
Date of disclosure of the study information | 2018/07/01 |
Last modified on | 2022/05/18 22:03:28 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2018/05/14 13:39:47 | ||
2 | Update | 2018/06/25 21:05:07 | Recruitment status Date of protocol fixation Anticipated trial start date |
|
3 | Update | 2019/03/22 12:05:56 | Date of IRB Last follow-up date |
|
4 | Update | 2019/03/22 12:07:36 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Organization Organization Address Address Tel |
|
5 | Update | 2022/05/18 22:03:28 | Recruitment status |